BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6244091)

  • 1. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.
    Findlay DM; deLuise M; Michelangeli VP; Ellison M; Martin TJ
    Cancer Res; 1980 Apr; 40(4):1311-7. PubMed ID: 6244091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells.
    Michelangeli VP; Findlay DM; Moseley JM; Martin TJ
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):129-41. PubMed ID: 6315797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
    Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ
    Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of calcitonin receptor internalization in lung cancer (BEN) and osteogenic sarcoma (UMR 106-06) cells.
    Findlay DM; Martin TJ
    J Bone Miner Res; 1986 Jun; 1(3):277-83. PubMed ID: 2845727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
    D'Santos CS; Gatti A; Poyner DR; Hanley MR
    Mol Pharmacol; 1992 May; 41(5):894-9. PubMed ID: 1375316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase-C-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells.
    Findlay DM; Michelangeli VP; Robinson PJ
    Endocrinology; 1989 Nov; 125(5):2656-63. PubMed ID: 2551660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal receptors of parathyroid hormone and calcitonin (author's transl)].
    Ardaillou R
    Nouv Presse Med; 1978 Dec; 7(45):4125-30. PubMed ID: 218163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.
    Ng KW; Livesey SA; Larkins RG; Martin TJ
    Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.
    Marx SJ; Aurbach GD
    Endocrinology; 1975 Aug; 97(2):448-53. PubMed ID: 169126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line.
    Hunt NH; Ellison M; Underwood JC; Martin TJ
    Br J Cancer; 1977 Jun; 35(6):777-84. PubMed ID: 194616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line.
    Findlay DM; deLuise M; Michelangeli VP; Martin TJ
    J Endocrinol; 1981 Feb; 88(2):271-81. PubMed ID: 6259268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
    Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ
    Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calcitonin receptor: characterization and processing.
    Raue F; Schneider HG; Ziegler R
    Prog Clin Biol Res; 1990; 332():67-79. PubMed ID: 2158663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amplification of the heterologous response of adenylate cyclase in colonic tumors: relation to tissue lipid composition].
    Bershteĭn LM; Kovaleva IG; Pravosudov IV
    Vopr Med Khim; 1988; 34(3):71-4. PubMed ID: 3420815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous desensitization of calcitonin receptors and calcitonin-dependent adenylate cyclase in T47D cells.
    Schneider HG; Raue F; Koppold A; Ruf W; Ziegler R
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):373-8. PubMed ID: 8388616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of catecholamine activation of adenylate cyclase by the number of active beta-adrenergic receptors: theoretical considerations on the role of receptor diffusion in the cell membrane.
    Swillens S
    J Cyclic Nucleotide Res; 1982; 8(2):71-82. PubMed ID: 6294157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-associated changes of the catecholamine-sensitive adenylate cyclase in glioma cells doubly transformed with Moloney sarcoma virus.
    Higashida H; Miki N; Tanaka T; Kato K; Nakano T; Nagatsu T; Kano-Tanaka K
    J Cell Physiol; 1982 Feb; 110(2):107-13. PubMed ID: 6279681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
    D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
    Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.